The analysis of whole blood, plasma, serum and urine is a most insightful method in clinical research. Since the sensitivity of analytical instrumentations systems has improved steadily in recent years, research results and reliability have increased as well.
In clinical applications, analytical instruments unfold a multitude of benefits:
- They support the quality of human life. The concentration of medications in Therapeutic Drug Monitoring (TDM), is assured, even though this may change according to age and health conditions and is dependent on gender, genetic constitution or interferences with other drugs.
- They help to save lives, particularly when it comes to time-critical situations, e.g. through acute intoxication, medical or drug abuse.
- They analyze over- and undersupply of vitamins, minerals and trace elements
- They are applied in genomics, proteomics and metabolomics.
- They uncover fraud in sports, particularly in animal or human doping. At the same time, analytical systems support health protection of animals and humans, even in the long-term.
Clinical applications benefit from Shimadzu’s complete portfolio covering chromatography and mass spectrometry (GC, GC-MS, GC-MS/MS, HPLC, UHPLC, LC-MS, LC-MS/MS), spectroscopy (UV-Vis, FTIR, AAS, EDX, ICP-OES), life sciences (MALDI-(TOF)-MS), microchip-electrophoresis, biopharmaceutical (aggregate sizer) and the observation of medical microbubbles in targeted drug delivery using the HPV-X2 ultra high-speed camera.
Shimadzu breaks new grounds by rethinking the use of mature technologies to develop new unique systems such as the iMScope TRIO. It combines an optical microscope with a mass spectrometer for insights on the molecular level. For next-generation brain science, Shimadzu provides LABNIRS, an imaging technology for visualization of brain functions by functional near-infrared spectroscopy (fNIRS).
Application Handbook Clinical Release 2- Download now!
- Download PDF (16 MB)
For Research Use Only. Not for use in diagnostic procedures. Not available in USA, Canada and China.